CADENCE PHARMACEUTICALS, INC COM STK
CADX
CADX was delisted on the 18th of March, 2014.
78 hedge funds and large institutions have $337M invested in CADENCE PHARMACEUTICALS, INC COM STK in 2013 Q2 according to their latest regulatory filings, with 78 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
29% less call options, than puts
Call options by funds: $100K | Put options by funds: $141K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $8K | +$8.36K | +1,200 | New |
|
|
DADC
77
D.A. Davidson & Co
Great Falls,
Montana
| $6K | +$6.97K | +1,000 | New |
|
78
Dimensional Fund Advisors
Austin,
Texas
| $1K | +$697 | +100 | New |
|
CADX Hedge Fund Activity: Q2 2013 in Review
78 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in CADENCE PHARMACEUTICALS, INC COM STK (CADX) for Q2 2013, worth a combined $337M.
Buyers outnumbered sellers: 78 funds opened new CADX positions and 0 closed out — a net gain of 78 holders — while 0 added to existing stakes and 0 trimmed.
- 78 institutional investors held CADENCE PHARMACEUTICALS, INC COM STK (CADX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $337M of CADENCE PHARMACEUTICALS, INC COM STK stock for Q2 2013.
- 78 funds opened new CADENCE PHARMACEUTICALS, INC COM STK positions in Q2 2013 and 0 closed out, a net change of +78 holders.
Based on aggregated 13F filings for Q2 2013.